Journal of Nursing ›› 2019, Vol. 26 ›› Issue (2): 39-44.doi: 10.16460/j.issn1008-9969.2019.02.039
Previous Articles Next Articles
Effectiveness of Sodium Citrate Solution and Heparin in Maintenance of Hemodialysis Catheters: A Meta Analysis
ZHU Ya-li1, YANG Chao2, FAN Xiang-hong3
- 1. Dept. of Nursing Adminsitration, Minda Hospital Affiliated to Hubei University for Nationalities, Enshi 445000, China;
2. School of Health Sciences, Wuhan University, Wuhan 430000, China;
3. Dept. of Nursing Administration,Renmin Hospital of Wuhan University, Wuhan 430000, China
CLC Number:
- R459.5
| [1] 2016 USRDS Annual DataReport/Volume 2-Esrd in the United States[S].United States Renal Data System,2016:369. [2] 中国医院协会血液净化中心管理分会血液净化通路学组.中国血液透析用血管通路专家共识(第1版)[J].中国血液净化,2014,13(8):549-558. [3] 伍刚,王荣,刘佳玮,等.日本最新(2015)血液透析血管通路指南解读[J].中国血液净化,2016,16(8):551-554. [4] Yon C K, Low C L, Sodium Citrate 4% Versus Heparin as a Lock Solution in Hemodialysis Patients with Central Venous Catheters[J].Am J Health-Syst Pharm, 2013(70):131-136. [5] MacRae J M, Dojcinovic I, et al. Citrate 4% Versus Heparin and the Reduction of Thrombosis Study (CHARTS)[J].Clin J Am Soc Nephrol,2008(3):369-374. [6] Weijmer M C, van den Dorpel M A, Van de Ven P J, et al.Randomized,Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-locking Solution in Hemodialysis Patients[J].J Am Soc Nephrol,2005,16(9):2769-2777. [7] 王方利. 维持性血液透析患者其Cuff导管应用不同抗凝剂的封存效果对比评价[J]. 国际泌尿系统杂志, 2016,36(6):899-903. [8] Grudzinski L, Quinan P, Kwok S, et al.Sodium Citrate 4% Locking Solution for Central Venous Dialysis Catheters an Effective, More Cost-efficient Alternative to Heparin[J].Nephrol Dial Transplant,2007(22):471-476. [9] 曹正江,李梨. 带Cuff中心静脉导管两种封管剂效果比较[J]. 武警医学, 2014,25(6):547-549. DOI:10.14010/j.cnki.wjyx.2014.06.016. [10] 王明波,王自良,谭永顺. 枸橼酸钠与肝素钠应用于血液透析患者封存Cuff导管的安全性和有效性对照研究[J]. 实用药物与临床,2016, 19(7):869-872. DOI:10.14053/j.cnki.ppcr.201607021. [11] 赵宇亮,杨济桥,张凌,等.枸橼酸和肝素封管液预防血液透析长期留置导管相关感染的Meta分析[J].中华肾脏病杂志,2013(8):574-582. [12] 韩新,曹艳佩,杨晓莉,等.经中心静脉导管血液透析患者不同种类封管液的应用进展[J].护士进修杂志,2016,31(6):507-510. DOI:10.16821/j.cnki.hsjx.2016.06.009. [13] 胡雁. 循证护理学[M].北京:人民卫生出版社,2012:76. [14] 江金燕,汪新妹,许晓雅.普外科术后患者静脉导管感染因素分析与对策[J].护士进修杂志,2013(23):2191-2193. [15] Power A, Duncan N, Singh S K, et al.Sodium Citrate versus Hepafin Catheter Locks for Cuffed Central Venous Catheters:A Single-center Randomized Controlled Trial[J]. Am J Kidney Dis,2009,53(6):1034-1041. [16] 岳琴琴,陈小波,祁华,等.血透中枸橼酸钠和肝素对静脉穿刺留置导管封管的比较研究[J].现代护理,2002,8(11):831. [17] 戎殳,叶朝阳,孙丽君,等.46.7%枸橼酸钠溶液在血液透析患者长期留置导管封管的应用[J]. 中华肾脏病杂志,2007(2):110-112. [18] 陈静,李玲玲,戎殳. 46.7%枸橼酸钠用于血液透析患者长期留置导管封管[J]. 护理学杂志,2009,24(15):15-16. [19] 唐建,伍秋蓉,刘小芳,等.枸橼酸钠用于维持性血液透析留置导管封管的临床观察[J]. 海南医学, 2011,22(14): 25-27. [20] 冉玉力,叶敏,谭华. 不同封管方法在血液透析留置导管并高危出血患者中的应用[J].实用中西医结合临床,2012,12(3):53-54. [21] 陈肖蕾,王婷立,钟慧,等. 肝素封管液与4%枸橼酸钠封管液在无肝素血液透析中的应用比较[J]. 四川大学学报(医学版),2013,44(4):693-695. DOI:10.13464/j.scuxbyxb.2013.04.011. [22] 金艳鸿,尹璐. 三种封管液对血滤患者中心静脉导管封管效果的比较研究[J]. 中国医药导报,2017,14(28):178-180. [23] Dogra G K, Herson H, Hutchison B, et al.Preventlon of Tunneled Hemodialysis Catheter-related Infections Using Catheter Restrlcted Fillng with Gentamicin and Citrate: A Randomized Controlled Study[J]. JASN,2002,13(8):2133-2139.DOI:10.1097/01.ASN.0000022890.29656.22. [24] Marcel C W, Yvette J D, Francien J V, et al.Superior Antimicrobial Activity of Trisodium Citrate over Heparin for Cathheter Locking[J]. Nephrol Dial Transplant, 2002,17:2189-2195. [25] 鄢建军,童辉,韩敏.深静脉留置透析导管患者置管并发症原因分析及护理[J].护理学杂志,2008,23(11):36-37. [26] Shanks R M, Sargent J L, Martinez R M,et al.Catheter Lock Solutions Influence Staphylococcal Biofilm Formation on Abiotic Surfaces[J]. Nephrol Dial Transplant, 2006,21(8):2247-2255. [27] 赵海霞,于洋,崔天蕾,等.维持性血液透析患者采用不同抗凝剂封存Cuff导管的临床对照观察[J].肾脏病与透析肾移植杂志,2014,23(6):539-542. [28] 孙钦龙,陈尔真.肝素在脓毒症患者治疗中的意义[J].中华危重病急救医学, 2017,29(12):1144-1147. [29] 温尊甲,沈梅芬,王濯,等.生理盐水与肝素钠盐水行PICC冲管效果Meta分析[J].护理学报,2017,24(1):42-47. DOI:10.16460/j.issn1008-9969.2017.01.042. [30] 殷贵兰,傅荣,宋玉磊.102例维持性血液透析患者生活质量及其影响因素分析[J].护理学报, 2017,24(2):1-4. DOI:10.16460/j.issn1008-9969.2017.02.001. |
|